The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

Share Price Information for Alpha Growth (ALGW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.85
Bid: 1.80
Ask: 1.90
Change: 0.15 (8.82%)
Spread: 0.10 (5.556%)
Open: 1.75
High: 1.85
Low: 1.70
Prev. Close: 1.70
ALGW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Confirm Previous Announced/Issued Shares Admission

17 Sep 2020 13:00

RNS Number : 2336Z
Alpha Growth PLC
17 September 2020
 

17 September 2020

 

 

Alpha Growth plc

("Alpha", or the "Company")

Confirmation of Previously Announced Issued Shares to Admission

The Company confirms the admission of previously announced issued shares totaling 34,873,357 as of 18 September 2020.

The Company's issued share capital is still 240,815,959 ordinary shares. The Company does not hold any Ordinary Shares in Treasury. The total voting rights continues to be 240,815,959 shares. This figure above may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

** END **

 

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman 

info@algwplc.com

Pello Capital Limited

+44 (0) 20 7710 9610

Mark Treharne

mt@pellocapital.com

 

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

 

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

 

Forward Looking Statements Disclaimer

 

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document. Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks. Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

 

Important Notice

 

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.

This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act), and may not be offered or sold, directly or indirectly, in or into the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States. This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, the Republic of South Africa, Japan or any jurisdiction where to do so might constitute a violation of local securities laws or regulations (a Prohibited Jurisdiction). This announcement and the information contained herein are not for release, publication or distribution, directly or indirectly, to persons in a Prohibited Jurisdiction unless permitted pursuant to an exemption under the relevant local law or regulation in any such jurisdiction.

Pello Capital Limited (Pello) is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Pello is acting solely as the Company's broker and placing agent in relation to the Placing and for no one else in connection with the contents of this announcement and will not regard any other person (whether or not a recipient of this announcement) as its client in relation to the contents of this announcement nor will Pello be responsible to anyone other than the Company for providing the protections afforded to their clients or for providing advice in relation to the contents of this announcement. Apart from the responsibilities and liabilities, if any, which may be imposed on Pello by FSMA or the regulatory regime established thereunder, Pello accepts no responsibility whatsoever, and makes no representation or warranty, express or implied, for the contents of this announcement including its accuracy, completeness or verification or for any other statement made or purported to be made by it, or on behalf of it, the Company or any other person, in connection with the Company and the contents of this announcement, whether as to the past or the future. Pello accordingly disclaims all and any liability whatsoever, whether arising in tort, contract or otherwise (save as referred to above), which it might otherwise have in respect of the contents of this announcement or any such statement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBCGDCDSBDGGL
Date   Source Headline
30th Nov 20202:06 pmRNSSecond Price Monitoring Extn
30th Nov 20202:01 pmRNSPrice Monitoring Extension
30th Nov 202011:06 amRNSSecond Price Monitoring Extn
30th Nov 202011:00 amRNSPrice Monitoring Extension
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
26th Nov 20202:06 pmRNSSecond Price Monitoring Extn
26th Nov 20202:00 pmRNSPrice Monitoring Extension
4th Nov 20207:00 amRNSCorporate Update
17th Sep 20201:00 pmRNSConfirm Previous Announced/Issued Shares Admission
10th Sep 20207:00 amRNSHolding(s) in Company
9th Sep 20206:24 pmRNSHolding(s) in Company
9th Sep 20206:20 pmRNSHolding(s) in Company
7th Sep 20204:41 pmRNSSecond Price Monitoring Extn
7th Sep 20204:36 pmRNSPrice Monitoring Extension
7th Sep 20202:06 pmRNSSecond Price Monitoring Extn
7th Sep 20202:01 pmRNSPrice Monitoring Extension
4th Sep 20202:17 pmRNSPublication of a Prospectus
19th Aug 20207:00 amRNSAppointment of Pello Capital Ltd and Placing
3rd Aug 20207:00 amRNSHolding(s) in Company
20th Jul 20207:00 amRNSCorporate Update
8th Jul 202011:05 amRNSSecond Price Monitoring Extn
8th Jul 202011:00 amRNSPrice Monitoring Extension
3rd Jul 20207:00 amRNSHolding(s) in Company
1st Jul 20207:00 amRNSHolding(s) in Company
24th Jun 20207:00 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSHolding(s) in Company
29th May 20207:00 amRNSDirector/PDMR Dealing and Issue of Shares
28th May 20207:00 amRNSHalf-year Report
27th May 20204:40 pmRNSHolding(s) in Company
21st May 20206:20 pmRNSHolding(s) in Company
6th May 20207:00 amRNSHolding(s) in Company
1st May 202011:06 amRNSSecond Price Monitoring Extn
1st May 202011:00 amRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSPeriodic Corporate Update
23rd Apr 20209:05 amRNSSecond Price Monitoring Extn
23rd Apr 20209:00 amRNSPrice Monitoring Extension
21st Apr 20204:41 pmRNSSecond Price Monitoring Extn
21st Apr 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20204:41 pmRNSSecond Price Monitoring Extn
30th Mar 20204:37 pmRNSPrice Monitoring Extension
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:37 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSHolding(s) in Company
19th Mar 20205:35 pmRNSExercise of Warrants and Total Voting Rights
19th Mar 20205:30 pmRNSHolding(s) in Company
12th Mar 20202:06 pmRNSSecond Price Monitoring Extn
12th Mar 20202:01 pmRNSPrice Monitoring Extension
9th Mar 202011:00 amRNSPrice Monitoring Extension
26th Feb 20205:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.